InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Hopper Jonathan Mark, Chief Medical Officer. Officer active across 1 companies, notably Vericel Corp. In total, 11 filings have been logged. The latest transaction was disclosed on 2 April 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations11 total
US$32,9403,472 shares@ US$9.48730.0020% mcap67.1% of flow
Common Stock
SEC:0001140361-26-013334·
€32,9403,472 shares@ €9.48730.0020% mcap16.8% of flow
Common Stock
SEC:0001140361-26-013334:0·
€97,62910,000 shares@ €9.76290.0058% mcap49.9% of flow
Common Stock
SEC:0001593968-22-000613:0·
01,750 shares0
Common Stock
SEC:0001593968-22-000517:0·
01,625 shares0
Common Stock
SEC:0001593968-22-000470:0·
0650 shares0
Common Stock
SEC:0001593968-22-000423:0·
0650 shares0
Common Stock
SEC:0001593968-22-000423·
€9,7391,000 shares@ €9.73890.0006% mcap19.8% of flow
Common Stock
SEC:0001593968-21-002569·
€9,7391,000 shares@ €9.73890.0006% mcap5.0% of flow
Common Stock
SEC:0001593968-21-002569:0·
€6,409694 shares@ €9.23520.0004% mcap13.1% of flow
Common Stock
SEC:0001593968-21-001776·
€6,409694 shares@ €9.23520.0004% mcap3.3% of flow
Common Stock
SEC:0001593968-21-001776:0·
11 of 11 declarations
About Hopper Jonathan Mark
Jonathan Mark Hopper serves as Chief Medical Officer at Vericel Corp. He is responsible for the medical leadership of the company, overseeing research and development initiatives and ensuring compliance with medical standards.
